Balloon dilation during esophageal cancer surgery
Part of Digestive system clinical trials.
This trial tests whether expanding a balloon inside the esophagus during keyhole surgery can reduce a serious complication called anastomotic leak. If you have esophageal cancer and are scheduled for a minimally invasive Ivor Lewis esophagectomy, you may be eligible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have been diagnosed with esophageal cancer (confirmed by a biopsy).
- You are planning to have a minimally invasive Ivor Lewis esophagectomy with the goal of curing the cancer.
- You have not had any previous surgery on your esophagus or stomach.
- You are able to understand and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two balloon inflation times (30 seconds vs 60 seconds) to see which works better for treating narrow spots in the esophagus that form after esophageal atresia repair.
This study tests whether a paclitaxel-coated balloon can keep the esophagus (food pipe) open longer in people with a stubborn benign narrowing. It aims to improve swallowing by reducing how often the narrowing needs repeat stretching.
This trial tests a minimally invasive surgery to remove part of the esophagus and stomach for esophageal cancer. It may help people whose cancer has not spread and who are healthy enough for this procedure.
This study tests a cooling balloon device to treat trouble swallowing caused by advanced esophageal cancer. It aims to open up the esophagus so you can eat more easily.
This study compares two ways to create a bypass between your stomach and small intestine using a special endoscope. It is for people with a blocked stomach outlet, if surgery or stents are not a good option for them.
This study tests a specific, minimally invasive surgery plan for removing esophagus cancer. It may help by reducing invasiveness while still aiming for a “radical” cancer removal after the right kind of prior treatment.
Hear when a new Delayed Gastric Conduit Emtpying (DGCE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.